Sterling Biotech Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
801
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
2
Sterling Biotech General Information
Description
Manufacturer of pharmaceutical products focused on businesses having strong entry barriers, with potential for scale enhancement. The company is engaged in the production of lovastatin, simvastatin ammonium salt, daunorubicin, doxorubicin, epirubicin, idarubicin and zoledronic acid and other drugs used to treat certain cancers.
Contact Information
Website
www.sterlingbiotech.in(Operating Subsidiary)
Corporate Office
- 601, Windfall Building, Sahar Plaza Complex
- J.B. Nagar, Andheri Kurla Road, Andheri-East
- Mumbai, Maharashtra 400059
- India
Corporate Office
- 601, Windfall Building, Sahar Plaza Complex
- J.B. Nagar, Andheri Kurla Road, Andheri-East
- Mumbai, Maharashtra 400059
- India
Sterling Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sterling Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sterling Biotech Patents
Sterling Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2597092-A1 | A process for purification of lovastatin | Inactive | 24-Nov-2011 | ||
| US-20100105916-A1 | Processes for preparing donepezil | Inactive | 29-Oct-2008 | ||
| CA-2666208-A1 | A process for the preparation of e-3-[2-(7-chloro-2-quinolinyl)ethenyl] benzaldehyde, a key intermediate for synthesizing montelukast acid and its salt | Inactive | 23-Jul-2008 | ||
| US-20100022777-A1 | Process for the preparation of e-3-[2-(7-chloro-2-quinolinyl)ethenyl]benzaldehyde | Inactive | 23-Jul-2008 | C07D215/18 |
Sterling Biotech Executive Team (6)
| Name | Title | Board Seat |
|---|---|---|
| Nitin Sandesara | Chief Executive Officer, Managing Director and Chairman | |
| Chetan Sandesara | Joint Managing Director and Executive Director | |
| Philip Chacko | Managing Director | |
| Jitendra Sharma | Vice President of Marketing and Procurement |
Sterling Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sterling Biotech Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Torrent Cables (Manufacturing Unit in Vadodara) | 16-Oct-2005 | Buildings and Property | |||
| Rallis (Gelatin Business) | 01-Jan-2004 | Merger/Acquisition | Specialty Chemicals |
Sterling Biotech Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Sterling Biotech ( API business ) | Pharmaceuticals | Mumbai, India |
Sterling Biotech FAQs
-
When was Sterling Biotech founded?
Sterling Biotech was founded in 1985.
-
Who is the CEO of Sterling Biotech?
Nitin Sandesara is the CEO of Sterling Biotech.
-
Where is Sterling Biotech headquartered?
Sterling Biotech is headquartered in Mumbai, India.
-
What is the size of Sterling Biotech?
Sterling Biotech has 801 total employees.
-
What industry is Sterling Biotech in?
Sterling Biotech’s primary industry is Pharmaceuticals.
-
Is Sterling Biotech a private or public company?
Sterling Biotech is a Private company.
-
What is the current valuation of Sterling Biotech?
The current valuation of Sterling Biotech is .
-
What is Sterling Biotech’s current revenue?
The current revenue for Sterling Biotech is .
-
When was Sterling Biotech acquired?
Sterling Biotech was acquired on 30-Aug-2024.
-
Who acquired Sterling Biotech?
Sterling Biotech was acquired by Zydus Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
